Companies / Amerigo Scientific / Recombinant Human DRAK2 (STK17B) (N-GST tag)
Amerigo Scientific

Recombinant Human DRAK2 (STK17B) (N-GST tag) | Amerigo Scientific

DRAK2 is a member of the serine/threonine kinase family and is related to death-associated protein kinase that triggers apoptosis. DRAK2 is selectively important for T-cell survival and inhibition of DRAK2 has therapeutic potential for autoimmune disease. T-cell survival depends on a balance of T-cell receptor and co-stimulatory signals and deficiency of DRAK2 can affect autoimmune disease susceptibility without generalized suppression of the immune system (3).

Reviews


No reviews yet

ABOUT THE COMPANY

Amerigo Scientific is a distribution company focused on providing critical products and services to the biomedical and life science research communities. Although a new company, Amerigo Scientific's founder has had more than 20 years of rich experience in the biomedical and biochemical fields, and has established close contacts with key personnel in...
READ MORE